These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23250630)

  • 1. Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?
    Singh M; Bedi US
    Curr Atheroscler Rep; 2013 Jan; 15(1):294. PubMed ID: 23250630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic plaque regression - the role of statin therapy.
    Sastry P; Kaski JC
    Drugs Today (Barc); 2010 Aug; 46(8):601-8. PubMed ID: 20830320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque burden, microstructures and compositions underachieving very low LDL-C levels.
    Kataoka Y; Andrews J; Puri R; Psaltis PJ; Nicholls SJ
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):122-132. PubMed ID: 28107247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.
    Lee SE; Chang HJ; Sung JM; Park HB; Heo R; Rizvi A; Lin FY; Kumar A; Hadamitzky M; Kim YJ; Conte E; Andreini D; Pontone G; Budoff MJ; Gottlieb I; Lee BK; Chun EJ; Cademartiri F; Maffei E; Marques H; Leipsic JA; Shin S; Choi JH; Chinnaiyan K; Raff G; Virmani R; Samady H; Stone PH; Berman DS; Narula J; Shaw LJ; Bax JJ; Min JK
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1475-1484. PubMed ID: 29909109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients.
    Clark D; Puri R; Nissen SE
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):873-880. PubMed ID: 33048622
    [No Abstract]   [Full Text] [Related]  

  • 7. Statin treatment and progression of atherosclerotic plaque burden.
    Grobbee DE; Bots ML
    Drugs; 2003; 63(9):893-911. PubMed ID: 12678574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins.
    Zhao L; Ma D; Wang L; Su X; Feng L; Zhu L; Chen Y; Hao Y; Wang X; Feng J
    Front Immunol; 2023; 14():1301051. PubMed ID: 38143759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.
    Budoff M; Brent Muhlestein J; Le VT; May HT; Roy S; Nelson JR
    Clin Cardiol; 2018 Jan; 41(1):13-19. PubMed ID: 29365351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerotic plaque regression: fact or fiction?
    Shanmugam N; Román-Rego A; Ong P; Kaski JC
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):311-7. PubMed ID: 20549322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
    Shiomi M; Koike T; Ito T
    Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins.
    Cai A; Zhou Y; Li L
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124206
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins Disrupt Macrophage Rac1 Regulation Leading to Increased Atherosclerotic Plaque Calcification.
    Healy A; Berus JM; Christensen JL; Lee C; Mantsounga C; Dong W; Watts JP; Assali M; Ceneri N; Nilson R; Neverson J; Wu WC; Choudhary G; Morrison AR
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):714-732. PubMed ID: 31996022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Control-Theoretic Model of Atherosclerosis.
    Formanowicz D; Krawczyk JB; Perek B; Formanowicz P
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review.
    Kouhpeikar H; Delbari Z; Sathyapalan T; Simental-Mendía LE; Jamialahmadi T; Sahebkar A
    Curr Atheroscler Rep; 2020 May; 22(5):19. PubMed ID: 32458165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving coronary plaque regression: a decades-long battle against coronary artery disease.
    Manubolu VS; Budoff MJ
    Expert Rev Cardiovasc Ther; 2022 Apr; 20(4):291-305. PubMed ID: 35466832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of atherosclerosis.
    Arsenault BJ; Kritikou EA; Tardif JC
    Curr Cardiol Rep; 2012 Aug; 14(4):443-9. PubMed ID: 22706914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance for lowering C-reactive protein with statins.
    Arévalo-Lorido JC
    Ann Med; 2016 Nov; 48(7):516-524. PubMed ID: 27355392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of statins on the progression of atherosclerotic renovascular disease.
    Cheung CM; Patel A; Shaheen N; Cain S; Eddington H; Hegarty J; Middleton RJ; Cowie A; Mamtora H; Kalra PA
    Nephron Clin Pract; 2007; 107(2):c35-42. PubMed ID: 17713349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.